Published in Nat Biotechnol on January 07, 2007
Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell (2008) 14.17
Stem cells and liver regeneration. Gastroenterology (2009) 3.40
Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal (2011) 3.31
The terminology of teratocarcinomas and teratomas. Nat Biotechnol (2007) 3.03
A 3D bioprinting system to produce human-scale tissue constructs with structural integrity. Nat Biotechnol (2016) 2.20
Endometrial regenerative cells: a novel stem cell population. J Transl Med (2007) 2.19
In vivo maturation of functional renal organoids formed from embryonic cell suspensions. J Am Soc Nephrol (2012) 1.81
Efficient direct reprogramming of mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression. Cell (2012) 1.74
Biomimetic nanofibrous scaffolds for bone tissue engineering. Biomaterials (2011) 1.63
Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res (2015) 1.57
Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells Dev (2010) 1.51
Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells (2008) 1.46
Stem/progenitor cells in lung development, injury repair, and regeneration. Proc Am Thorac Soc (2008) 1.45
Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS One (2010) 1.44
Chondrogenic differentiation of amniotic fluid-derived stem cells. J Mol Histol (2007) 1.44
Bone regeneration and stem cells. J Cell Mol Med (2011) 1.41
Risk factors in the development of stem cell therapy. J Transl Med (2011) 1.38
Cell-based therapy in ischemic stroke. Expert Rev Neurother (2008) 1.33
Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol (2008) 1.33
Rare somatic cells from human breast tissue exhibit extensive lineage plasticity. Proc Natl Acad Sci U S A (2013) 1.31
Human stem cell delivery for treatment of large segmental bone defects. Proc Natl Acad Sci U S A (2010) 1.28
Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery. Am J Pathol (2010) 1.22
Staged in vitro reconstitution and implantation of engineered rat kidney tissue. Proc Natl Acad Sci U S A (2007) 1.20
CD44+/CD105+ human amniotic fluid mesenchymal stem cells survive and proliferate in the ovary long-term in a mouse model of chemotherapy-induced premature ovarian failure. Int J Med Sci (2012) 1.20
Endothelial differentiation of amniotic fluid-derived stem cells: synergism of biochemical and shear force stimuli. Stem Cells Dev (2009) 1.20
Putative dental pulp-derived stem/stromal cells promote proliferation and differentiation of endogenous neural cells in the hippocampus of mice. Stem Cells (2008) 1.19
Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells. Stem Cells Transl Med (2011) 1.19
Stromal cells and stem cells in clinical bone regeneration. Nat Rev Endocrinol (2015) 1.17
Advances in musculoskeletal tissue engineering: moving towards therapy. Organogenesis (2011) 1.16
Fetal stem cells from extra-embryonic tissues: do not discard. J Cell Mol Med (2008) 1.14
Human amniotic fluid stem cell preconditioning improves their regenerative potential. Stem Cells Dev (2011) 1.12
Reviewing and updating the major molecular markers for stem cells. Stem Cells Dev (2013) 1.11
New strategies to optimize kidney recovery and preservation in transplantation. Nat Rev Nephrol (2012) 1.11
Endogenous and exogenous stem cells: a role in lung repair and use in airway tissue engineering and transplantation. J Biomed Sci (2010) 1.11
Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther (2012) 1.10
Endothelial differentiation of adipose-derived stem cells from elderly patients with cardiovascular disease. Stem Cells Dev (2010) 1.09
Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy. World J Stem Cells (2010) 1.09
Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells. Cell Reprogram (2010) 1.08
Comparative study of immune regulatory properties of stem cells derived from different tissues. Stem Cells Dev (2013) 1.08
Placental perivascular cells for human muscle regeneration. Stem Cells Dev (2010) 1.08
Current status of islet cell transplantation. J Hepatobiliary Pancreat Surg (2008) 1.07
Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues. J R Soc Interface (2010) 1.06
Concise review: mesenchymal stem cells for diabetes. Stem Cells Transl Med (2011) 1.06
Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment. Cell Commun Signal (2012) 1.06
Fluid dynamics in developmental biology: moving fluids that shape ontogeny. HFSP J (2008) 1.06
Merging high-quality biochemical fractionation with a refined flow cytometry approach to monitor nucleocytoplasmic protein expression throughout the unperturbed mammalian cell cycle. Nat Protoc (2013) 1.05
Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats. PLoS One (2012) 1.05
Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation. Stem Cells Dev (2013) 1.04
Amniotic fluid stem cells produce robust mineral deposits on biodegradable scaffolds. Tissue Eng Part A (2009) 1.03
Concise review: clinical programs of stem cell therapies for liver and pancreas. Stem Cells (2013) 1.03
Nanofiber-based delivery of bioactive agents and stem cells to bone sites. Adv Drug Deliv Rev (2012) 1.03
Clinical grade adult stem cell banking. Organogenesis (2009) 1.03
ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective. Pediatr Surg Int (2009) 1.02
Stem cell approaches for diabetes: towards beta cell replacement. Genome Med (2011) 1.02
Biliary tree stem cells, precursors to pancreatic committed progenitors: evidence for possible life-long pancreatic organogenesis. Stem Cells (2013) 1.02
Amniocytes can serve a dual function as a source of iPS cells and feeder layers. Hum Mol Genet (2010) 1.02
Stem cell platforms for regenerative medicine. Clin Transl Sci (2009) 1.01
Evaluation of endothelial cells differentiated from amniotic fluid-derived stem cells. Tissue Eng Part A (2012) 1.01
Plasticity of human menstrual blood stem cells derived from the endometrium. J Zhejiang Univ Sci B (2011) 1.01
Efficient siRNA-mediated prolonged gene silencing in human amniotic fluid stem cells. Nat Protoc (2010) 1.00
Role of mesenchymal stem cell-derived microvesicles in tissue repair. Pediatr Nephrol (2013) 1.00
Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds. Biomaterials (2009) 1.00
Comprehensive characterization of mesenchymal stem cells from human placenta and fetal membrane and their response to osteoactivin stimulation. Stem Cells Int (2012) 0.99
Creation of new bone by the percutaneous injection of human bone marrow stromal cell and HA/TCP suspensions. Tissue Eng Part A (2008) 0.99
Hepatic differentiation of amniotic epithelial cells. Hepatology (2011) 0.99
Cloned, CD117 selected human amniotic fluid stem cells are capable of modulating the immune response. PLoS One (2011) 0.99
Human amniotic fluid as a potential new source of organ specific precursor cells for future regenerative medicine applications. J Urol (2010) 0.98
Bioprinted amniotic fluid-derived stem cells accelerate healing of large skin wounds. Stem Cells Transl Med (2012) 0.98
Injection of amniotic fluid stem cells delays progression of renal fibrosis. J Am Soc Nephrol (2012) 0.98
Engineering tissue from human embryonic stem cells. J Cell Mol Med (2008) 0.98
Sox2 suppression by miR-21 governs human mesenchymal stem cell properties. Stem Cells Transl Med (2013) 0.97
Hypoxic conditioned medium from human amniotic fluid-derived mesenchymal stem cells accelerates skin wound healing through TGF-β/SMAD2 and PI3K/Akt pathways. Int J Mol Sci (2014) 0.97
Tissue Engineering with Nano-Fibrous Scaffolds. Soft Matter (2008) 0.96
Tissue engineering: current strategies and future directions. Chonnam Med J (2011) 0.96
Recent progress in satellite cell/myoblast engraftment -- relevance for therapy. FEBS J (2013) 0.96
Isolation and characterization of porcine amniotic fluid-derived multipotent stem cells. PLoS One (2011) 0.96
Amniotic fluid stem cell migration after intraperitoneal injection in pup rats: implication for therapy. Pediatr Surg Int (2010) 0.96
Microfluidic sample preparation for diagnostic cytopathology. Lab Chip (2013) 0.95
A novel method to derive amniotic fluid stem cells for therapeutic purposes. BMC Cell Biol (2010) 0.95
Menstrual blood-derived mesenchymal stem cells differentiate into functional hepatocyte-like cells. J Zhejiang Univ Sci B (2013) 0.95
In vitro cardiomyogenic potential of human amniotic fluid stem cells. J Tissue Eng Regen Med (2011) 0.95
Constructing kidney-like tissues from cells based on programs for organ development: toward a method of in vitro tissue engineering of the kidney. Tissue Eng Part A (2010) 0.95
Human amniotic fluid stem cell injection therapy for urethral sphincter regeneration in an animal model. BMC Med (2012) 0.94
Porcine pancreas extracellular matrix as a platform for endocrine pancreas bioengineering. Biomaterials (2013) 0.94
Mesenchymal Stem Cells - Sources and Clinical Applications. Transfus Med Hemother (2008) 0.94
Clonal characterization of rat muscle satellite cells: proliferation, metabolism and differentiation define an intrinsic heterogeneity. PLoS One (2010) 0.94
Amniotic fluid and amniotic membrane stem cells: marker discovery. Stem Cells Int (2012) 0.94
Regenerative medicine strategies for treating neurogenic bladder. Int Neurourol J (2011) 0.93
Adipose-derived mesenchymal cells for bone regereneration: state of the art. Biomed Res Int (2013) 0.93
In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells. J Cell Mol Med (2011) 0.93
The LARGE principle of cellular reprogramming: lost, acquired and retained gene expression in foreskin and amniotic fluid-derived human iPS cells. PLoS One (2010) 0.92
Spindle shaped human mesenchymal stem/stromal cells from amniotic fluid promote neovascularization. PLoS One (2013) 0.92
Human amniotic fluid stem cells as a model for functional studies of genes involved in human genetic diseases or oncogenesis. Oncotarget (2011) 0.92
Multipotent stromal stem cells from human placenta demonstrate high therapeutic potential. Stem Cells Transl Med (2012) 0.92
Ontological differences in first compared to third trimester human fetal placental chorionic stem cells. PLoS One (2012) 0.91
Stem cell therapy to protect and repair the developing brain: a review of mechanisms of action of cord blood and amnion epithelial derived cells. Front Neurosci (2013) 0.91
Microfluidic immunomagnetic cell separation using integrated permanent micromagnets. Biomicrofluidics (2013) 0.91
Human amniotic fluid stem cells have a potential to recover ovarian function in mice with chemotherapy-induced sterility. BMC Dev Biol (2013) 0.91
Therapeutic potential of adipose tissue-derived stem cells for liver failure according to the transplantation routes. J Korean Surg Soc (2011) 0.91
Adipose tissue as a stem cell source for musculoskeletal regeneration. Front Biosci (Schol Ed) (2011) 0.90
Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell (2006) 8.48
The transcriptional network for mesenchymal transformation of brain tumours. Nature (2009) 8.44
Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet (2006) 7.64
Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell (2011) 7.41
Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell (2010) 5.77
Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells (2009) 5.69
Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A (2004) 4.70
Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet (2009) 4.28
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
Human hepatic stem cells from fetal and postnatal donors. J Exp Med (2007) 4.15
Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet (2011) 3.95
Quantitative mass spectrometry identifies insulin signaling targets in C. elegans. Science (2007) 3.46
A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature (2009) 3.44
Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A (2002) 3.35
A quantitative analysis software tool for mass spectrometry-based proteomics. Nat Methods (2008) 3.35
Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells (2010) 3.24
Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores. J Urol (2004) 3.15
Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell (2010) 3.08
Functional stoichiometry of the unitary calcium-release-activated calcium channel. Proc Natl Acad Sci U S A (2008) 3.07
Mapping the interacting domains of STIM1 and Orai1 in Ca2+ release-activated Ca2+ channel activation. J Biol Chem (2007) 3.05
The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat Biotechnol (2002) 2.89
Aggregation of STIM1 underneath the plasma membrane induces clustering of Orai1. Biochem Biophys Res Commun (2006) 2.89
Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? J Urol (2013) 2.81
Robotic-assisted laparoscopic partial nephrectomy: technique and initial clinical experience with DaVinci robotic system. Urology (2004) 2.68
Dissecting multiple steps of GLUT4 trafficking and identifying the sites of insulin action. Cell Metab (2007) 2.63
Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. Stem Cells (2010) 2.62
Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol (2013) 2.62
Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nat Med (2007) 2.57
The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J Proteome Res (2008) 2.53
Engineering complex tissues. Tissue Eng (2006) 2.53
Atlas - a data warehouse for integrative bioinformatics. BMC Bioinformatics (2005) 2.51
Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat Biotechnol (2002) 2.50
Adult stem cell therapy of female stress urinary incontinence. Eur Urol (2007) 2.48
Digestion and depletion of abundant proteins improves proteomic coverage. Nat Methods (2012) 2.48
Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection. Eur Urol (2010) 2.47
Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell (2013) 2.45
Defining the actual sensitivity and specificity of the neurosphere assay in stem cell biology. Nat Methods (2006) 2.43
Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol (2012) 2.39
Regulated ATP release from astrocytes through lysosome exocytosis. Nat Cell Biol (2007) 2.38
Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol (2002) 2.37
Retracted Autologous myoblasts and fibroblasts versus collagen for treatment of stress urinary incontinence in women: a randomised controlled trial. Lancet (2007) 2.35
Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy. Proc Natl Acad Sci U S A (2009) 2.33
Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature (2012) 2.32
Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells (2004) 2.32
Total reconstruction of the vesico-urethral junction. BJU Int (2008) 2.28
Carbon nanotube applications for tissue engineering. Biomaterials (2006) 2.25
A genetic program promotes C. elegans longevity at cold temperatures via a thermosensitive TRP channel. Cell (2013) 2.25
Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity. BMC Med Genomics (2011) 2.24
Rational design of true monomeric and bright photoactivatable fluorescent proteins. Nat Methods (2012) 2.21
Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci U S A (2007) 2.19
Anterior urethral valves and diverticula in children: a result of ruptured Cowper's duct cyst? BJU Int (2004) 2.19
Phosphoproteomic analysis of human embryonic stem cells. Cell Stem Cell (2009) 2.19
Optimizing the outcome of microsurgical subinguinal varicocelectomy using isosulfan blue: a prospective randomized trial. J Urol (2006) 2.15
Application of inkjet printing to tissue engineering. Biotechnol J (2006) 2.12
The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology (2011) 2.09
Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat. J Mol Cell Cardiol (2006) 1.99
Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer (2013) 1.97
Generation of histocompatible tissues using nuclear transplantation. Nat Biotechnol (2002) 1.97
Gene therapy: can neural stem cells deliver? Nat Rev Neurosci (2006) 1.95
Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets. Hepatology (2011) 1.94
Early diagnosis and straight forward surgery of an asymptomatic primary angiosarcoma of the kidney led to long-term survival. Int J Urol (2006) 1.92
Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice. Proc Natl Acad Sci U S A (2008) 1.91
Extremely long-lived nuclear pore proteins in the rat brain. Science (2012) 1.91
Association of lower urinary tract symptoms and chronic ischaemia of the lower urinary tract in elderly women and men: assessment using colour Doppler ultrasonography. BJU Int (2008) 1.83
Neuropilin-1-mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migration. J Biol Chem (2003) 1.82
Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo. J Biol Chem (2007) 1.81
Anderson-Hynes dismembered pyeloplasty performed using the da Vinci robotic system. Urology (2002) 1.81
Antiangiogenic properties of gold nanoparticles. Clin Cancer Res (2005) 1.78
Controlled fabrication of a biological vascular substitute. Biomaterials (2005) 1.76
Arginyltransferase is an ATP-independent self-regulating enzyme that forms distinct functional complexes in vivo. Chem Biol (2011) 1.76
C. elegans phototransduction requires a G protein-dependent cGMP pathway and a taste receptor homolog. Nat Neurosci (2010) 1.76
Global analysis of posttranslational protein arginylation. PLoS Biol (2007) 1.75
Pegasys: software for executing and integrating analyses of biological sequences. BMC Bioinformatics (2004) 1.74
Interleukin-6 regulation of prostate cancer cell growth. J Cell Biochem (2005) 1.73
Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents. Proc Natl Acad Sci U S A (2006) 1.73
Expression profile of an operationally-defined neural stem cell clone. Exp Neurol (2005) 1.71
Automatic validation of phosphopeptide identifications from tandem mass spectra. Anal Chem (2007) 1.70
Cell-seeded tubularized scaffolds for reconstruction of long urethral defects: a preclinical study. Eur Urol (2012) 1.69
Large-scale study of clinical impact of PSA velocity: long-term PSA kinetics as method of differentiating men with from those without prostate cancer. Urology (2007) 1.69
Robotic-assisted laparoscopic partial nephrectomy: surgical technique and clinical outcomes at 1 year. BJU Int (2008) 1.68
Tissue engineering, stem cells, and cloning: opportunities for regenerative medicine. J Am Soc Nephrol (2004) 1.68
Longitudinal PSA changes in men with and without prostate cancer: assessment of prostate cancer risk. Prostate (2005) 1.68
Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial. J Urol (2003) 1.67
Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis. J Proteome Res (2008) 1.67
Robotic Anderson-Hynes pyeloplasty: 5-year experience of one centre. BJU Int (2007) 1.67
Long-term magnetic resonance imaging of stem cells in neonatal ischemic injury. Ann Neurol (2010) 1.67
Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells. J Steroid Biochem Mol Biol (2005) 1.67
Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies. J Allergy Clin Immunol (2010) 1.65
Arginylation regulates myofibrils to maintain heart function and prevent dilated cardiomyopathy. J Mol Cell Cardiol (2012) 1.64